Nyxoah S.A.

NASDAQ:NYXH

7.72 (USD) • At close June 14, 2024
Bedrijfsnaam Nyxoah S.A.
Symbool NYXH
Munteenheid USD
Prijs 7.72
Beurswaarde 265,262,288
Dividendpercentage 0%
52-weken bereik 4 - 20
Industrie Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Olivier Taelman
Website https://www.nyxoah.com

An error occurred while fetching data.

Over Nyxoah S.A.

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert,

Vergelijkbare Aandelen

Science 37 Holdings, Inc. logo

Science 37 Holdings, Inc.

SNCE

5.75 USD

Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc.

VRDN

12.44 USD

RxSight, Inc. logo

RxSight, Inc.

RXST

57.89 USD

MeiraGTx Holdings plc logo

MeiraGTx Holdings plc

MGTX

4.49 USD

Incannex Healthcare Limited logo

Incannex Healthcare Limited

IXHL

0.84 USD

Inotiv, Inc. logo

Inotiv, Inc.

NOTV

1.76 USD

Repare Therapeutics Inc. logo

Repare Therapeutics Inc.

RPTX

3.8 USD

OrganiGram Holdings Inc. logo

OrganiGram Holdings Inc.

OGI

1.525 USD

Sight Sciences, Inc. logo

Sight Sciences, Inc.

SGHT

6.56 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)